Among them, Sombroek and collaborators demonstrated that primary tumors (renal carcinoma, cervical cancer, breast cancer and melanoma) negatively modulate the development and activity of dendritic cells through factors regulated by cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) [50]. This evidence concerns the gene PTGS1 and breast cancer.